ReviewFrontiers in immunology2026

Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety.

Haiyv Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.